| ²é¿´: 152 | »Ø¸´: 1 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
cheungsoberľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
Çó·Òë2¾ä»°
|
||
| ´Ó2.5mg/LµâËáÄÆÆð¹Çϸ°ûÖеÄBIP/¦Â-actin¸ßÓÚ¶ÔÕÕ×é(P<0£®05)£»´Ó10mg/LµâËáÄÆÆð£¬¸÷¼Óµâ×éµÄCHOP£¯GAPDH±È¶ÔÕÕ×é¸ß(P<0.05)¡£MCM3µ°°×±í´ïÄܹ»±»ÒÂÃ¹ËØËùϵ÷£¬¶øÔÚÆäËüŨ¶ÈµÄµâ×÷ÓÃϾùÓв»Í¬³Ì¶ÈµÄ±í´ïÉϵ÷,µ«ÎÞÃ÷ÏÔ¼ÁÁ¿·´Ó¦¹ØÏµ¡£ |
» ²ÂÄãϲ»¶
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ12È˻ظ´
385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏר˶283Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703Çóµ÷¼Á383·Ö
ÒѾÓÐ5È˻ظ´
323Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ8È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
goodtimega
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 4
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 8138.7
- É¢½ð: 570
- ºì»¨: 1
- Ìû×Ó: 1489
- ÔÚÏß: 527.5Сʱ
- ³æºÅ: 820248
- ×¢²á: 2009-08-02
- רҵ: ¸ß·Ö×Ó²ÄÁϽṹÓëÐÔÄÜ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
cheungsober(½ð±Ò+10,VIP+0):ллÀÏʦµÄ°ïÖú 12-6 09:49
cheungsober(½ð±Ò+10,VIP+0):ллÀÏʦµÄ°ïÖú 12-6 09:49
| A comparable analysis is performed from 2.5mg / L sodium iodide with bone cells in BIP / ¦Â-actin control group (P <0.05) to 10mg / L sodium iodide and the iodization of all groups CHOP / GAPDH up to control group higher (P <0.05). The result indicates that MCM3 protein expression can be reduced by tunicamycin, while in other concentrations of iodine in varying degrees under the action of increased expression. However there is no significant dose-response relationship. |
2Â¥2009-12-05 22:34:35














»Ø¸´´ËÂ¥